James Breitmeyer
Founder presso ONCTERNAL THERAPEUTICS, INC.
Patrimonio netto: 295 083 $ in data 31/03/2024
Posizioni attive di James Breitmeyer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Director/Board Member | 01/09/2015 | - |
| Chief Executive Officer | 01/09/2015 | - | |
| Founder | 01/01/1997 | - | |
| President | 01/09/2015 | - | |
Oncternal Oncology, Inc.
 Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Chief Executive Officer | - | - |
Rebalance Health, Inc.
 Rebalance Health, Inc. Pharmaceuticals: OtherHealth Technology Rebalance Health, Inc. is a company that offers a sleep aid product called Meet Dream, which is made of natural and organic ingredients. The company is based in Boulder, CO and was founded by Justin A. Hai, who has been the CEO since incorporation. The product is designed to provide a restorative sleep experience every night and has been clinically tested to reduce hot flashes, lower anxiety, and unleash testosterone. | Director/Board Member | - | - |
Storia della carriera di James Breitmeyer
Precedenti posizioni note di James Breitmeyer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| OTONOMY | Director/Board Member | 19/06/2018 | 15/02/2023 |
| Independent Dir/Board Member | 19/06/2018 | 15/02/2023 | |
| ZOGENIX, INC. | Director/Board Member | 01/03/2014 | 07/03/2022 |
| Chief Tech/Sci/R&D Officer | 01/08/2012 | 01/02/2013 | |
| Independent Dir/Board Member | 01/03/2014 | 07/03/2022 | |
| BAVARIAN NORDIC A/S | Corporate Officer/Principal | 12/02/2013 | 01/07/2015 |
| CADENCE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2006 | 31/12/2012 |
Applied Molecular Evolution, Inc.
 Applied Molecular Evolution, Inc. Medical/Nursing ServicesHealth Services Applied Molecular Evolution, Inc. provides healthcare support services. It develops novel human biotherapeutics cytokines, hormones, and enzymes. The company was founded in 1989 by Bill Huse and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/12/2001 | 01/08/2006 |
The Baim Institute for Clinical Research
 The Baim Institute for Clinical Research Miscellaneous Commercial ServicesCommercial Services The Baim Institute for Clinical Research manages clinical trial data in a range of therapeutic areas for commercial, academic, and scientific purposes. The firm engages in the design, management, and data analysis of clinical trials in the U.S. and internationally. It offers clinical CRO services that include trial design, project management, site management and monitoring, statistical analysis, medical monitoring and oversight, clinical endpoint event identification and adjudication and medical writing services; and data management, including electronic data capture services. The company was founded by Donald S. Baim and Richard E. Kuntz in 1993 and is headquartered in Boston, MA. | Chief Executive Officer | 01/02/2000 | 01/07/2001 |
| President | 01/02/2000 | 01/07/2001 | |
| ░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - | |
| ░░░░░░░░░ | - | - | |
| ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Formazione di James Breitmeyer
| University of California, Santa Cruz | Undergraduate Degree |
| Washington University School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 15 |
| Danimarca | 2 |
| Svizzera | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 6 |
| Director/Board Member | 5 |
| Chief Executive Officer | 4 |
Settori
| Health Technology | 11 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BAVARIAN NORDIC A/S | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| Aziende private | 12 |
|---|---|
Applied Molecular Evolution, Inc.
Applied Molecular Evolution, Inc. Medical/Nursing ServicesHealth Services Applied Molecular Evolution, Inc. provides healthcare support services. It develops novel human biotherapeutics cytokines, hormones, and enzymes. The company was founded in 1989 by Bill Huse and is headquartered in San Diego, CA. | Health Services |
Bavarian Nordic, Inc.
 Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | Commercial Services |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Tokalas, Inc.
 Tokalas, Inc. Pharmaceuticals: MajorHealth Technology Tokalas, Inc. operated as a biopharmaceutical company. It developed targeted therapies for the treatment of cancer. The company was founded in 2013 and was headquartered in Del Mar, CA. | Health Technology |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Health Technology |
The Baim Institute for Clinical Research
The Baim Institute for Clinical Research Miscellaneous Commercial ServicesCommercial Services The Baim Institute for Clinical Research manages clinical trial data in a range of therapeutic areas for commercial, academic, and scientific purposes. The firm engages in the design, management, and data analysis of clinical trials in the U.S. and internationally. It offers clinical CRO services that include trial design, project management, site management and monitoring, statistical analysis, medical monitoring and oversight, clinical endpoint event identification and adjudication and medical writing services; and data management, including electronic data capture services. The company was founded by Donald S. Baim and Richard E. Kuntz in 1993 and is headquartered in Boston, MA. | Commercial Services |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
| Serono International SA | |
Oncternal Oncology, Inc.
Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Health Technology |
Rebalance Health, Inc.
Rebalance Health, Inc. Pharmaceuticals: OtherHealth Technology Rebalance Health, Inc. is a company that offers a sleep aid product called Meet Dream, which is made of natural and organic ingredients. The company is based in Boulder, CO and was founded by Justin A. Hai, who has been the CEO since incorporation. The product is designed to provide a restorative sleep experience every night and has been clinically tested to reduce hot flashes, lower anxiety, and unleash testosterone. | Health Technology |
- Borsa valori
- Insiders
- James Breitmeyer
- Esperienza
